PURPOSE: Antidepressant use has been associated with cognitive impairment in older persons. We sought to examine whether this association might reflect an indication bias. METHODS: A total of 544 community-dwelling hypertensive men aged ≥65 years completed the Hopkins Verbal Learning Test at baseline and 1 year. Antidepressant medications were ascertained by the use of medical records. Potential confounding by indications was examined by adjusting for depression-related diagnoses and severity of depression symptoms using multiple linear regression, a propensity score, and a structural equation model (SEM). RESULTS: Before adjusting for the indications, a one unit cumulative exposure to antidepressants was associated with -1.00 (95% confidence interval [CI], -1.94, -0.06) point lower HVLT score. After adjusting for the indications using multiple linear regression or a propensity score, the association diminished to -0.48 (95% CI, -0.62, 1.58) and -0.58 (95% CI, -0.60, 1.58), respectively. The most clinical interpretable empirical SEM with adequate fit involves both direct and indirect paths of the two indications. Depression-related diagnoses and depression symptoms significantly predict antidepressant use (p < .05). Their total standardized path coefficients on Hopkins Verbal Learning Test score were twice (0.073) or as large (0.034) as the antidepressant use (0.035). CONCLUSION: The apparent association between antidepressant use and memory deficit in older persons may be confounded by indications. SEM offers a heuristic empirical method for examining confounding by indications but not quantitatively superior bias reduction compared with conventional methods.
PURPOSE: Antidepressant use has been associated with cognitive impairment in older persons. We sought to examine whether this association might reflect an indication bias. METHODS: A total of 544 community-dwelling hypertensivemen aged ≥65 years completed the Hopkins Verbal Learning Test at baseline and 1 year. Antidepressant medications were ascertained by the use of medical records. Potential confounding by indications was examined by adjusting for depression-related diagnoses and severity of depression symptoms using multiple linear regression, a propensity score, and a structural equation model (SEM). RESULTS: Before adjusting for the indications, a one unit cumulative exposure to antidepressants was associated with -1.00 (95% confidence interval [CI], -1.94, -0.06) point lower HVLT score. After adjusting for the indications using multiple linear regression or a propensity score, the association diminished to -0.48 (95% CI, -0.62, 1.58) and -0.58 (95% CI, -0.60, 1.58), respectively. The most clinical interpretable empirical SEM with adequate fit involves both direct and indirect paths of the two indications. Depression-related diagnoses and depression symptoms significantly predict antidepressant use (p < .05). Their total standardized path coefficients on Hopkins Verbal Learning Test score were twice (0.073) or as large (0.034) as the antidepressant use (0.035). CONCLUSION: The apparent association between antidepressant use and memory deficit in older persons may be confounded by indications. SEM offers a heuristic empirical method for examining confounding by indications but not quantitatively superior bias reduction compared with conventional methods.
Authors: Gail Kuslansky; Mindy Katz; Joe Verghese; Charles B Hall; Pablo Lapuerta; Gia LaRuffa; Richard B Lipton Journal: Arch Clin Neuropsychol Date: 2004-01 Impact factor: 2.813
Authors: Joseph V Agostini; Mary E Tinetti; Ling Han; Peter Peduzzi; Joanne M Foody; John Concato Journal: J Gen Intern Med Date: 2007-09-25 Impact factor: 5.128
Authors: Sean Hennessy; Warren B Bilker; Charles E Leonard; Jesse Chittams; Cristin M Palumbo; Jason H Karlawish; Yu-Xiao Yang; Ebbing Lautenbach; William B Baine; Joshua P Metlay Journal: J Clin Epidemiol Date: 2007-05-10 Impact factor: 6.437
Authors: Ling Han; Joseph L Goulet; Melissa Skanderson; Harini Bathulapalli; Stephen L Luther; Robert D Kerns; Cynthia A Brandt Journal: Pain Med Date: 2019-01-01 Impact factor: 3.750